entertainment -WSS

entertainment

author：hotspot 2025-09-29 22:36:31 - browse：112

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

WSS

Investigation reveals sickle cell patients pressured into sterilizations

In shift, Texas to cover initial consult for Afghan baby's gene therapy

FDA poised to publish guidelines for clinical trial diversity

At JPM 2024, hospital systems pitch financial strength to investors

Physician assistants need a new name. Here's what it should be

Questions and answers about ramping up H5N1 bird flu vaccine

focus

entertainment

knowledge

Sports medicine is finally prioritizing gender equality

JPM pitch from hospitals? Revenue streams outside of patient care

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

UnitedHealth argues against case alleging wrongful AI care denials

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Bright Health sells Medicare Advantage business to Molina

Study finds gene variants tied to breast cancer risk in Black women

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Eyeing GLP

knowledge

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Making the case for fair compensation in clinical trials

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Investigation reveals sickle cell patients pressured into sterilizations

Life science postdocs should get big pay hike, NIH panel says

Questions and answers about ramping up H5N1 bird flu vaccine

hotspot

hotspot

leisure time

focus